Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Regulatory Considerations for Working with the FDA vs. the EMA Premier Consulting This webinar will compare approval processes, types (and costs) of agency meetings, expedited programs, pediatric plans, and more. We will discuss: –... February 28, 2023 7:00am Tuning Into Radiotherapeutics: Considerations for Oncology Trials Premier Research Radiopharmaceutical therapy is emerging as a safe and effective targeted approach to treating many types of cancer. Clinical trials for these therapie... February 28, 2023 3:00am Modernising haematological malignancy adverse event assessment and reporting Lan-Lan Smith, Gita Thanarajasingam Targeted agents, immune and cellular therapies and other novel agents have led to dramatic shifts in the treatment of many hematologic malignancies (H... 5 months ago | 63 mins Sepsis Overview: Challenges and Solutions for Laboratories Mirta Gamez, M.T.(A.S.C.P.), C.L.S. Sepsis presents a global healthcare crisis, with more people dying from sepsis than from prostate cancer, colon cancer, breast cancer and AIDS combine... 3 years ago | 51 mins Regulatory Considerations for Working with the FDA vs. the EMA Premier Consulting – Kimberly Cummings, Vice President, Regulatory Affairs, & Maurice Bancsi, Director, Regulatory Affairs This webinar will compare approval processes, types (and costs) of agency meetings, expedited programs, pediatric plans, and more. We will discuss: –... 4 months ago | 60 mins Regulatory Considerations for Working with the FDA vs. the EMA Premier Consulting – Kimberly Cummings, Vice President, Regulatory Affairs, & Maurice Bancsi, Director, Regulatory Affairs This webinar will compare approval processes, types (and costs) of agency meetings, expedited programs, pediatric plans, and more. We will discuss: –... 2 months ago | 60 mins The Expanding Role of RWE in Rare Studies Premier Consulting – Shari Medendorp, MPH, President, and Nach Davé, RPh, MS, Vice President, Development Strategy Real-world evidence is increasingly important in drug development as the medical and pharma communities recognize the data’s potential for predicting ... 4 months ago | 57 mins New-Drug Development: Succeeding With the FDA Premier Research Moving an investigational new drug through FDA approval can seem like a monumental task. It’s a complex and demanding journey, but understanding the s... 2 months ago | 43 mins Maximizing Productivity in Urinary Tract Infection Testing Ranjana Hawaldar, M.B.B.S., M.D. In this webinar, Dr. Ranjana Hawaldar will discuss a solution to help laboratories screen out samples that will not grow pathogenic bacteria prior to ... 3 years ago | 53 mins Leveraging the Target Product Profile (TPP) to Maximize Breakthrough Potential Premier Consulting - Robb Lawrence, Senior Vice President, Commercial Strategy The target product profile (TPP) is a strategic framework and tool commonly used in the development of novel biopharmaceutical products. Unfortunately... 10 months ago | 60 mins Load more
